Free Trial
ASX:RAC

Race Oncology (RAC) Stock Price, News & Analysis

Race Oncology logo

About Race Oncology Stock (ASX:RAC)

Advanced Chart

Key Stats

Today's Range
N/A
50-Day Range
N/A
52-Week Range
N/A
Volume
76,322 shs
Average Volume
N/A
Market Capitalization
A$211.94 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive RAC Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Race Oncology and its competitors with MarketBeat's FREE daily newsletter.

RAC Stock News Headlines

"I'm risking my reputation on this"
Behind closed doors, away from the mainstream media's eyes, the smartest minds in crypto are all seeing the same signals. They're positioning themselves for something unprecedented. And after 17 million podcast downloads and over 600 insider interviews, I finally connected all the dots… What I discovered was so explosive, so potentially life-changing, that I had to put it all in a book.
See More Headlines

RAC Stock Analysis - Frequently Asked Questions

Race Oncology Limited (ASX:RAC) issued its quarterly earnings results on Wednesday, February, 27th. The company reported ($0.03) earnings per share (EPS) for the quarter. Race Oncology had a negative net margin of 345.18% and a negative trailing twelve-month return on equity of 71.34%.

Based on aggregate information from My MarketBeat watchlists, some other companies that Race Oncology investors own include Mesoblast (MESO), Pilbara Minerals (PLS), Mount Gibson Iron (MGX), Minotaur Exploration (MEP), Invictus Energy (IVZ), EHang (EH) and Ginkgo Bioworks (DNA).

Company Calendar

Last Earnings
2/27/2019
Today
7/11/2025

Industry, Sector and Symbol

Stock Exchange
ASX
Sector
Medical
Industry
Biotechnology
Sub-Industry
Business Services
Current Symbol
ASX:RAC
CIK
N/A
Fax
N/A
Employees
12,700
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
A($0.08)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-A$13.82 million
Net Margins
-345.18%
Pretax Margin
N/A
Return on Equity
-71.34%
Return on Assets
-38.63%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
9.32
Quick Ratio
23.71

Sales & Book Value

Annual Sales
A$4 million
Price / Sales
0.00
Cash Flow
N/A
Price / Cash Flow
24.29
Book Value
A$0.11 per share
Price / Book
N/A

Miscellaneous

Outstanding Shares
170,430,000
Free Float
N/A
Market Cap
A$211.94 million
Optionable
Not Optionable
Beta
1.74
Options Trading Made Easy - Download Now Cover

Learn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.

Get This Free Report

This page (ASX:RAC) was last updated on 7/11/2025 by MarketBeat.com Staff
From Our Partners